Patent Assignment
Reel/Frame 043341/0571
Change of Name
Recorded: 2017-07-26
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Oligonucleotides Containing 2'O-Modified Purines
Patent:
7,101,993 →
Application:
07/967,267 →
Gapped Oligonucleotides
Patent:
7,015,315 →
Application:
08/465,866 →
Carbohydrate or 2' -Modified Oligonucleotides Having Alternating Internucleoside Linkages
Pyrimidine Derivatives and Oligonucleotides Containing Same
Patent:
39,324 →
Application:
10/080,074 →
Process for Manufacturing Purified Phosphorodiamidite
Protection of Nucleosides
Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Process for the Synthesis of Oligomeric Compounds
Antisense Oligonucleotide Modulation of STAT3 Expression
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jan 28, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0349 →
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Change of Name
Aug 29, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028866/0511 →
Assignment of Assignor's Interest
Mar 11, 2021
From: IONIS PHARMACEUTICALS, INC.
To: BIOGEN MA INC.
Reel/Frame 055608/0382 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →